Bristol Myers Squibb Co: Form 10-Q for the period ended Jun 30, 2023
Filed with the SEC on Jul 27, 2023 and accepted by EDGAR at Jul 27, 2023, 12:28 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-04-01 to 2023-06-30 | $11.23bn | us-gaap:Revenues |
| Revenue | 6 months2023-01-01 to 2023-06-30 | $22.56bn | us-gaap:Revenues |
| Cost of revenue | 3 months2023-04-01 to 2023-06-30 | $2.88bn | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2023-01-01 to 2023-06-30 | $5.44bn | us-gaap:CostOfGoodsAndServicesSold |
| Research and development | 3 months2023-04-01 to 2023-06-30 | $2.26bn | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2023-01-01 to 2023-06-30 | $4.58bn | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2023-04-01 to 2023-06-30 | $1.93bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2023-01-01 to 2023-06-30 | $3.70bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Interest expense | 3 months2023-04-01 to 2023-06-30 | $282.0m | us-gaap:InterestExpense |
| Interest expense | 6 months2023-01-01 to 2023-06-30 | $570.0m | us-gaap:InterestExpense |
| Income tax | 3 months2023-04-01 to 2023-06-30 | −$218.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2023-01-01 to 2023-06-30 | $285.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-04-01 to 2023-06-30 | $2.07bn | us-gaap:NetIncomeLoss |
| Net income | 6 months2023-01-01 to 2023-06-30 | $4.33bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-04-01 to 2023-06-30 | $0.99 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2023-01-01 to 2023-06-30 | $2.06 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-04-01 to 2023-06-30 | $0.99 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2023-01-01 to 2023-06-30 | $2.07 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-04-01 to 2023-06-30 | 2,102,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2023-01-01 to 2023-06-30 | 2,107,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2023-01-01 to 2023-06-30 | $4.86bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2023-01-01 to 2023-06-30 | $537.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2023-01-01 to 2023-06-30 | $2.39bn | us-gaap:PaymentsOfDividends |
| Share repurchases | 6 months2023-01-01 to 2023-06-30 | $1.16bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-06-30 | $8.37bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-06-30 | $28.07bn | us-gaap:AssetsCurrent |
| Total assets | At period end2023-06-30 | $93.49bn | us-gaap:Assets |
| Current liabilities | At period end2023-06-30 | $20.15bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-06-30 | $61.46bn | us-gaap:Liabilities |
| Long-term debt | At period end2023-06-30 | $34.66bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2023-06-30 | $2.41bn | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | At period end2023-06-30 | $3.02bn | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2023-06-30 | $31.97bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000014272-23-000152. Last ingested by Listed: Oct 29, 2026, 11:17 ET. Listed shows no prices and gives no investment advice.